DCSIMG

Drug trialled at city hospital ‘should be less expensive’

Health news

Health news

The manufacturer of a breast cancer drug trialled in Sheffield has been urged to reduce the treatment’s price - after it was rejected for wider NHS use on cost grounds.

The drug Kadcyla, made by Roche, can extend some patients’ lives by six months, but is currently priced at £90,000. It was tested at Weston Park Hospital.

Sir Andrew Dillon, chief executive of NHS rationing body NICE, said Roche should ‘do more’ to make Kadcyla available.

 

Comments

 
 

Back to the top of the page